Degenerative Mitral Regurgitation: Impact on Post-Procedural Gradient

Primary or degenerative mitral regurgitation (MR) occurs frequently. Even though surgery continues to be the standard treatment at present, it remains risky for one group of patients, which makes edge-to-edge mitral valve repair (MV-TEER) a viable alternative. 

Centera Valvula expandible

We are well aware that moderate to severe MR is associated with worse prognosis. However, post procedural mean gradient analysis (ppMG) has not been carried out exhaustively and the available data on primary MR remains limited. 

The study looked at 371 patients undergoing edge-to-edge repair with MitraClip, from the GISE and GIOTO registries. At the end of the procedure, 187 patients presented <3 mmHg ppMG, 77 >3/=4 mmHg ppMG and 107 >4 mmHg ppMG.

Primary end point was all cause death or hospitalization driven by cardiac failure within 12 months. 

There were no significant differences between the three groups of patients. Mean age was 85, and 51% were women. Also, 71.3% were hypertensive, 16.5% diabetic, 21.2% had chronic obstructive pulmonary disease (COPD), 40.4% presented atrial fibrillation, 22% had CAD and 45% had been hospitalized for cardiac failure. Also, 10% had a history of MI, 17% had had prior heart surgery and 70% were in functional class III-IV. STS mortality rate was 3.7%.

Leia também: EASTBOURNE Registry: Use of Sirolimus-Coated Balloons in Coronary Artery Disease.

Mean ejection fraction was 57%, and 4.6% had ≤35% ejection fraction. Echocardiographic values showed LV diastolic diameter 53, LV systolic diameter 35, end diastolic volume 110 ml and pulmonary artery systolic pressure 45 mmHg.

36% of patients received just one clip, while 59% received two. No relationship was found between the number of clips and higher ppMG. Patients with ppMG >3/=4 presented more residual MR >2+ by the end of the procedure vs the other two groups. 

After one year, no differences were found between the three groups in terms of mortality or hospitalization for cardiac failure. 

Leia também: Left Atrial Appendage Closure: As Effective in Men and Women?

At multivariable analysis, neither ppMG >4mmHg not ≥5 mmHg were predictors of bad evolution, though so the case for ppMG ≥4 mmHg together with residual MR ≥2+ (hazard ratio: 1.98; 95% confidence interval: [1.10–3.58]).

Conclusion

In this cohort of patients with degenerative MR treated with edge-to-edge repair, no link was found between post procedural mean gradient and one-year prognosis. However, a considerable number of patients did experience an increase in post procedural gradient and residual MR, and the combination of both factors seems to be a solid predictor of adverse events. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Postprocedural trans‐mitral gradient in patients with degenerative mitral regurgitation undergoing mitral valve transcatheter edge‐to‐edge repair.

Reference: Francesco De Felice, et al . Catheter Cardiovasc Interv. 2023;102:310–317.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...